NAD+ is getting a lot of attention in longevity circles. Here's a clear-eyed look at the evidence — what it supports, what remains uncertain, and who might benefit most.
Every post is written by physicians or the Mt. Baker Medical clinical team and reviewed by Dr. James Scribner, MD, FACEP — A4M Fellow and board-certified emergency physician. Sources are linked inline where possible; recommendations reflect current evidence and clinical practice.
